Global Immunohistochemistry Market to Reach US$ 4.9 Billion by 2032, Impelled by Increasing Product Demand for Effective Drug Development

December 08, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2024-2032," the global immunohistochemistry market size reached US$ 2.6 Billion in 2023. Immunohistochemistry is a laboratory method that uses antibodies to check for specific antigens in a tissue sample. These antibodies are usually linked to an enzyme or a fluorescent dye. It plays a crucial role in pathology, particularly in oncologic pathology, neuropathology, and hematopathology subspecialties. It is used to help diagnose various chronic diseases. It is also employed to differentiate between different types of cancers. Immunohistochemistry is extensively utilized in research activities to understand the distribution and localization of biomarkers as well as differentially expressed proteins in other parts of biological tissue.

Global Immunohistochemistry Market Trends:

The global market is majorly driven by the introduction of technologically advanced Immunohistochemistry solutions. In line with this, the rising implementation of automation and machine learning in IHC is creating a positive outlook for the market. Furthermore, rapid advancements in IHC protocols have catalyzed its demand in disease diagnosis. Apart from this, the increasing prevalence of chronic diseases and the growing geriatric population are significantly contributing to the market. Moreover, the numerous collaborations between regulatory outsourcing and pharmaceutical and biotechnology companies are positively influencing the market. Besides, the shifting preference for value-based healthcare solutions and the augmenting demand for targeted immunotherapy and biologic therapy in anticancer drug development are propelling the market. Additionally, the increasing incidences of cancer, neurodegenerative disorders, and tumors are providing a boost to the market. Other factors, including the launch of new products, acquisition and collaboration by key market players, and the growing number of diagnostic centers, are further expected to drive the market growth. On account of the factors above, the market is anticipated to reach a value of US$ 4.9 Billion by 2032, exhibiting a CAGR of 6.8% during 2024-2032. 

Market Summary:

  • On the basis of the product, the market has been categorized into antibodies (primary antibodies and secondary antibodies), equipment (slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others), reagents (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents), and kits.
  • Based on the application, the market has been classified into diagnostics (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases) and drug testing.
  • Based on the end use, the market has been categorized into hospitals and diagnostic laboratories, research institutes, and others.
  • On the basis of the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market. Some of the key players include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Immunohistochemistry Market to Reach US$ 4.9 Billion by 2032, Impelled by Increasing Product Demand for Effective Drug Development
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More